DocGo Inc. (NASDAQ:DCGO) Receives $11.83 Average Target Price from Brokerages

Shares of DocGo Inc. (NASDAQ:DCGOGet Free Report) have earned an average recommendation of “Buy” from the five research firms that are covering the firm, MarketBeat.com reports. Five analysts have rated the stock with a buy recommendation. The average 1 year price target among brokers that have updated their coverage on the stock in the last year is $11.83.

DCGO has been the subject of a number of research reports. Stifel Nicolaus reduced their price target on shares of DocGo from $12.00 to $11.00 and set a “buy” rating for the company in a research report on Friday, February 23rd. Needham & Company LLC reduced their price target on shares of DocGo from $14.00 to $10.00 and set a “buy” rating for the company in a research report on Thursday, February 29th. Cantor Fitzgerald reduced their price target on shares of DocGo from $13.00 to $11.00 and set an “overweight” rating for the company in a research report on Thursday, February 29th. Finally, Canaccord Genuity Group reduced their price target on shares of DocGo from $11.00 to $10.00 and set a “buy” rating for the company in a research report on Thursday, February 29th.

View Our Latest Report on DCGO

Insider Activity

In other DocGo news, Director Michael J. Burdiek bought 10,000 shares of DocGo stock in a transaction dated Thursday, March 14th. The stock was acquired at an average cost of $3.61 per share, with a total value of $36,100.00. Following the completion of the acquisition, the director now owns 571,595 shares of the company’s stock, valued at $2,063,457.95. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this link. Corporate insiders own 13.78% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in DCGO. AJOVista LLC acquired a new position in shares of DocGo during the fourth quarter worth about $25,000. Federated Hermes Inc. acquired a new position in shares of DocGo during the third quarter worth about $29,000. Royal Bank of Canada increased its stake in shares of DocGo by 226.3% during the first quarter. Royal Bank of Canada now owns 3,263 shares of the company’s stock worth $30,000 after acquiring an additional 2,263 shares during the period. Huntington National Bank acquired a new position in shares of DocGo during the second quarter worth about $30,000. Finally, Tower Research Capital LLC TRC grew its position in DocGo by 145.6% during the third quarter. Tower Research Capital LLC TRC now owns 5,908 shares of the company’s stock worth $31,000 after buying an additional 3,502 shares during the period. 56.44% of the stock is currently owned by institutional investors and hedge funds.

DocGo Trading Up 4.4 %

Shares of DCGO stock opened at $4.06 on Monday. The firm has a fifty day moving average price of $3.68 and a 200 day moving average price of $4.85. The company has a market cap of $422.93 million, a P/E ratio of 58.00, a PEG ratio of 0.39 and a beta of 0.91. DocGo has a 12 month low of $2.78 and a 12 month high of $10.82.

DocGo (NASDAQ:DCGOGet Free Report) last announced its quarterly earnings results on Wednesday, February 28th. The company reported $0.06 earnings per share for the quarter, missing analysts’ consensus estimates of $0.13 by ($0.07). DocGo had a net margin of 1.10% and a return on equity of 2.01%. The company had revenue of $199.25 million during the quarter, compared to analysts’ expectations of $195.48 million. On average, equities analysts forecast that DocGo will post 0.36 EPS for the current year.

About DocGo

(Get Free Report

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.

See Also

Analyst Recommendations for DocGo (NASDAQ:DCGO)

Receive News & Ratings for DocGo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocGo and related companies with MarketBeat.com's FREE daily email newsletter.